Rebecca Windsor DVM, DACVIM
Vice President of Veterinary Affairs at Gallant
Dr. Rebecca Windsor, DVM, DACVIM, is a board-certified veterinary neurologist with over 20 years of clinical experience and a strong record of scientific publication. She joined Gallant in 2025 and serves as Vice President of Veterinary Affairs.
Dr. Windsor specializes in veterinary regenerative medicine, with a focus on advancing FDA-approved, off-the-shelf mesenchymal stem cell therapies for pets. She develops educational platforms that translate the science, safety, and clinical efficacy of stem cell therapy for veterinary professionals. Since 2019, she has served as a Clinician Scientist at Ethos Discovery, where she leads the neurology research portfolio.
All published content
Science Library
Busting Myths Around Stem Cell Therapy
Read more
Blog
The Pathway to FDA Approval for Veterinary Stem Cell Therapies
Read more
Science Library
How Allogeneic Stem Cells are Thought to Be Immune-privileged
Read more
Blog
Understanding Immune Privilege in Allogeneic Stem Cell Therapy
Read more
Science Library
The Evolution from Autologous to Allogeneic Cell Therapies
Read more
Blog
From Autologous to Allogeneic: The Evolution of Stem Cell Therapies in Veterinary Medicine
Read more
Science Library
Stem Cells 101: What is A Mesenchymal Stem/Stromal Cell?
Read more
Blog
Stem Cells 101: What Pet Parents Should Know About Mesenchymal Stem Cells
Read more
Science Library
Ethical Considerations of Placebo controls and the Role of Historical Controls and Real-World Evidence in Clinical Trials
Read more
